Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 8,214 | 8,259 | 7,462 | 8,749 | 4,802 |
| Cost of Goods | 4,027 | 5,102 | 3,021 | N/A | 2,276 |
| Gross Profit | 4,187 | 3,157 | 4,441 | 14,369 | 2,526 |
| Operating Expenses | 24,003 | 21,110 | 18,847 | 23,001 | 18,081 |
| Operating Income | -19,789 | -17,851 | -14,385 | -14,252 | -15,279 |
| Interest Expense | 47 | 51 | 52 | 29 | 64 |
| Other Income | 109 | 38 | 627 | 230 | 43 |
| Pre-tax Income | -19,727 | -17,864 | -13,810 | -14,051 | -15,300 |
| Income Tax | N/A | N/A | N/A | 3 | N/A |
| Net Income Continuous | -19,727 | -17,864 | -13,810 | -14,054 | -15,300 |
| Net Income | $-19,727 | $-17,864 | $-13,810 | $-14,054 | $-15,300 |
| EPS Basic Total Ops | -1.60 | -1.60 | -1.40 | -1.40 | -1.80 |
| EPS Basic Continuous Ops | -1.66 | -1.65 | -1.32 | -1.31 | -1.82 |
| EPS Diluted Total Ops | -1.60 | -1.60 | -1.40 | -1.40 | -1.80 |
| EPS Diluted Continuous Ops | -1.66 | -1.65 | -1.32 | -1.31 | -1.82 |
| EBITDA(a) | $-18,564 | $-17,054 | $-13,306 | $-13,116 | $-14,510 |